Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_assertion description "[The data provide further evidence that targeted inhibition of MEK may be therapeutically effective for thyroid cancer, particularly if the PI3K and NF-kappaB pathways are concurrently inhibited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_assertion evidence source_evidence_literature NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_assertion SIO_000772 18651802 NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_assertion wasDerivedFrom befree-20140225 NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_assertion wasGeneratedBy ECO_0000203 NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP166089.RAclzAoZUM8Vqloitqj6r7mlqiW7Qa7A-4Z49UVwjoH6k130_provenance.